U.S. markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.92-0.43 (-1.52%)
At close: 4:00PM EDT

27.92 0.00 (0.00%)
After hours: 4:42PM EDT

Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
12/31/2020
Market Cap (intraday) 5
7.64B10.84B
Enterprise Value 3
7.05B10.76B
Trailing P/E
63.00N/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
31.99243.82
Price/Book (mrq)
9.20121.52
Enterprise Value/Revenue 3
30.2551.75
Enterprise Value/EBITDA 7
41.5866.88

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-51.87%
S&P500 52-Week Change 349.51%
52 Week High 371.91
52 Week Low 323.20
50-Day Moving Average 332.51
200-Day Moving Average 340.10

Share Statistics

Avg Vol (3 month) 31.08M
Avg Vol (10 day) 31.55M
Shares Outstanding 5269.5M
Implied Shares Outstanding 6N/A
Float 240.03M
% Held by Insiders 132.34%
% Held by Institutions 137.64%
Shares Short (Mar 14, 2021) 44.03M
Short Ratio (Mar 14, 2021) 44.78
Short % of Float (Mar 14, 2021) 42.57%
Short % of Shares Outstanding (Mar 14, 2021) 41.49%
Shares Short (prior month Feb 11, 2021) 42.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 51.00%
Operating Margin (ttm)67.74%

Management Effectiveness

Return on Assets (ttm)19.18%
Return on Equity (ttm)28.29%

Income Statement

Revenue (ttm)233.16M
Revenue Per Share (ttm)1.47
Quarterly Revenue Growth (yoy)6,391.30%
Gross Profit (ttm)176.62M
EBITDA 162.77M
Net Income Avi to Common (ttm)85.1M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)594.12M
Total Cash Per Share (mrq)2.2
Total Debt (mrq)6.78M
Total Debt/Equity (mrq)0.82
Current Ratio (mrq)7.86
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)22.69M
Levered Free Cash Flow (ttm)-20.56M